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ThoracoscopyAbstract Background: Pleural tissue can be harvested either by means of closed biopsies, thora-
coscopy or open surgical biopsies. Access to thoracoscopy and open surgical biopsies is limited
in many parts of the world and closed biopsies are therefore the preferred initial investigation (Dia-
con et al., 2003) [6].
Aim of the study: This study aimed to compare the diagnostic efﬁciency of image-assisted ANPB
with that of medical thoracoscopy in patients with exudative pleural effusion.
Patients and methods: Forty patients with non-diagnosed exudative pleural effusions were
recruited. All had a contrast-enhanced thoracic CT scan to assess pleural thickening. Patients were
randomly stratiﬁed by baseline pleural thickening, to either image-assisted Abrams’ pleural biopsy
(n= 20) or medical thoracoscopy biopsy (n= 20).
Results: Diagnostic sensitivity of image-assisted ANPB for 20 patients (group I) was 75% (15/
20), for group Ia was 60% (6/10), and for group Ib was 90% (9/10). Diagnostic sensitivity of tho-
racoscopy for 20 patients (group II) was 85% (17/20), for group IIa was 80% (8/10), and for group
IIb was 90% (9/10).
Conclusions: Image-assisted Abram-needle pleural biopsy is a primary alternative to thoracos-
copy in exudative pleural effusions associated with pleural thickening.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Exudative pleural effusions are frequently encountered in pul-
monary practice. Determination of a speciﬁc diagnosis can
represent a major challenge [1]. Barring a few exceptions, vir-
tually all patients presenting with pleural effusions should
therefore undergo pleural aspiration to categorize effusions
Figure 1 (A) Lt. sided circumferential pleural thickening
(>1 cm) with pleural effusion.
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ferential diagnosis, but also directs subsequent investigations
and management [2].
Pleural biopsy is indicated to improve the diagnostic yield
of unexplained pleural effusion, particularly when pleural car-
cinomatosis or tuberculosis is suspected [3].
Medical thoracoscopy for cases of exudative pleural effu-
sion not having any diagnosis by either clinical, radiologic, lab-
oratory, or cytologic investigation is the method that has been
performed routinely in many clinics [4]. In fact, 2010 British
Thoracic Society (BTS) pleural disease guideline state that tho-
racoscopy is the investigation of choice in exudative pleural
effusions where a diagnostic pleural aspiration is inconclusive
and malignancy is suspected [3]. However, despite a higher
diagnostic yield, there are several limitations including need
for expertise, cost, invasiveness and lack of availability in some
regions that restrict its widespread use [5,6].
The Abram’s and Cope needles began the era of closed
pleural biopsy providing a safe and easy bedside procedure
to evaluate suspected pleural effusion [7,8]. The standard
method of using the Abrams pleural biopsy ‘‘punch’’ is to take
one biopsy during a single aspiration and if this is negative to
repeat the procedure later at a different site [7]. The modiﬁed
Abrams pleural biopsy technique consisted of suctioning each
tissue sample into a syringe without removing the needle com-
pletely from the chest until the completion of the entire proce-
dure [9]. Recent studies have proposed that image guidance
may signiﬁcantly increase the yield of closed pleural biopsy
while decreasing the risk for complications. Both transthoracic
US and CT scanning have been utilized [2,10].
Aim of the study
The present research was done to evaluate and compare the
image-assisted Abram’s needle efﬁcacy versus medical thora-
coscopy in exudative pleural effusions.Figure 1 (B) US guided Abram needle pleural biopsy.Patients and methods
This work was carried out on 40 patients attended to in the
Chest Department, Tanta University Hospital during the peri-
od fromMay 2012 to August 2013. The patients presented with
exudative pleural effusions based on Light’s criteria [11], which
a speciﬁc diagnosis could not be determined by either clinical,
radiologic, laboratory, or cytologic investigations.
This study was performed in compliance with ethical rules
at our locality. Written informed consent was taken from each
patient after the detailed procedure and purpose of the study
was explained. Prothrombin time, activated partial thrombo-
plastin time (APTT), and platelet count were conﬁrmed to
be normal before biopsy. Patients with respiratory failure,
empyema, acute cardiac event, who had taken oral anticoagu-
lants were excluded from this work.
All patients underwent initial contrast-enhanced CT of the
Thorax, using Toshiba CT medical system with overlapping 5-
mm sections from the apex of the lungs to the costophrenic re-
cess. We measured the amount of parietal pleural thickening,
and participants were divided into those with maximum thick-
ening of less than 10 mm or 10 mm or more (Fig. 1).
The patients were randomized (using closed envelopes), di-
vided into two groups and they underwent pleural biopsy witheither; CT guided Abram’s needle (group I), or medical thora-
coscopy (group II). Each group was divided into two sub-
groups according to the parietal pleural thickening.
Combined image-assisted Abram needle pleural biopsy
Entry site
The entry site was selected as the most accessible part of the
lesion by looking at the mediastinal copy of the CT scans.
According to the scale located on CT scans, the entry point
was determined in two dimensions. Then, the entry site for
Abrams needle was marked on the skin of the patient.
US-guidance
After identiﬁcation of the entry site, local anesthetic was given,
with about 10 mL of 2% lidocaine inﬁltrated into the skin,
intercostal space, and parietal pleura. With the patient in a sit-
ting (preferred), prone or a supine position and under direct
US guidance (using sonoline-Antares machine (Siemens), with
probe C5), an Abram needle was inserted into the patient at
the entry site, to be advanced along the inner aspect of the tho-
racic wall and away from the lung, enabling successful biopsy
from the area of maximum pleural thickening.
Table 2 Non-diagnostic yield of both Abram’s and medical
thoracoscopy.
Assisted-ANPB M. thoracoscopy
5 3
Pl. Thickening
<1 cm >1 cm 3 2 2 1
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taken from the upper surface of the rib below the entry site)
was needed, but a second pass was done if the initial sample
was macroscopically unsatisfactory. No more than two biopsy
passes were made in any patient. A chest radiograph was done
2–4 h after the procedure to detect any pneumothorax.
Medical thoracoscopy
Medical thoracoscopy was done with a rigid thoracoscope
(Karl Storz, Germany) under mild sedation and local anesthe-
sia. Four to six biopsy specimens were taken.
The biopsy specimens (at least three macroscopically satis-
factory specimens) were immediately ﬁxed in formalin for his-
topathological examination, to identify malignant from benign
tissue. A biopsy specimen in an isotonic saline solution for
microbiological investigations was taken.
Statistical analysis
SPSS version 20 software was used for statistical analysis. Sen-
sitivities were compared using the v2 test (Chi Square test) with
p< 0.05 accepted as signiﬁcant.
Results
Image-assisted Abram needle, using the modiﬁed technique
was performed on 20 patients (group I), 13 male (65%) and
7 female (35%); the mean age was 49.25 ± 10.3 years. Thora-
coscopy was performed on 20 patients (group II), 11 (55%)
male and 9 (45%) female; the mean age was 47.1 ± 7.4 years.
There were no signiﬁcant differences as regards sex and age be-
tween the two studied groups.
Each group was divided into two subgroups according to
the parietal pleural thickening on enhanced CT. So, group
Ia; included 10 patients with pleural thickening less than
1 cm, and group Ib; included 10 patients with pleural thicken-
ing 1 cm or more. On the other line of the study, group IIa; in-
cluded 10 patients with pleural thickening less than 1 cm, and
group IIb; included 10 patients with pleural thickening 1 cm or
more.
Diagnostic sensitivity of image-assisted ANPB for 20 pa-
tients (group I) was 75% (15/20), and of thoracoscopy for 20
patients (group II) was 85% (17/20) (P= 0.27) (Table 1).
Diagnostic sensitivity of group Ia was 60% (6/10), and of
group IIa was 80% (8/10) (P= 0.35). Diagnostic sensitivity
of group Ib was 90% (9/10), and of group IIb was 90%
(9/10) (P= 1.00).Table 1 Distribution of diagnosed benign and malignant
lesions in the studied groups.
Benign lesion Malignant lesion
Assisted-ANPB 7 8
Pl. thickening
<1 cm >1 cm 3 4 3 5
M. thoracoscopy 8 9
Pl. thickening
<1 cm >1 cm 5 3 3 6Moreover, there were non-signiﬁcant differences between
subgroups Ia and Ib (P= 0.348) and IIa and IIb (P= 1.00).
The number of non-diagnosed cases in group I was 7 pa-
tients; 5 patients with pleural thickening less than 1 cm, and
2 patients with pleural thickening more than 1 cm. Three pa-
tients in group II were not diagnosed; 2 patients with pleural
thickening less than 1 cm, and one patient with pleural thick-
ening more than 1 cm. There was signiﬁcant difference in
non-diagnostic yield between groups I and II, that was in-
creased in group I (Table 2).
Discussion
During the past decade, thoracoscopic biopsy has become a
widely accepted means of diagnosis if ﬁndings from pleural
ﬂuid cytologic examination and blind pleural biopsy are non-
diagnostic. The advantages are its sensitivity of 91–98% for
the diagnosis of pleural malignancy and its potential therapeu-
tic beneﬁt, such as enabling talc pleurodesis. Thoracoscopy has
the disadvantage of requiring general anesthesia or sedation,
requiring chest tube drainage and inpatient stay, having the
potential of failure due to adhesions preventing pneumotho-
rax, being substantially more expensive than image-guided
biopsy, and having a higher complication rate [12,13].
Image-assisted biopsy is more likely to be diagnostic in the
presence of pleural thickening >10 mm, pleural nodularity,
pleural based mass lesions of >20 cm and solid pleural tumors
[14,15].
This study is the ﬁrst one worldwide that used combined
chest enhanced CT and transthoracic US-guided Abram nee-
dle pleural biopsy, in two consecutive steps, getting the beneﬁt
of the higher CT sensitivity with the demonstration of pleural
thickening and focal diseases [16], and of the advantage of US
including; less expensive, less radiation, and short examination
time [17].
In our study, out of 20 patients who underwent image-as-
sisted ANPB, 15 patients were diagnosed; 7 patients diagnosed
with benign disease and 8 patients diagnosed with malignant
disease, with an overall diagnostic sensitivity of 75%. Also,
out of 20 patients who underwent medical thoracoscopy, 17
patients were diagnosed; 8 patients diagnosed with a benign
disease and 9 patients diagnosed with malignant disease, with
overall diagnostic sensitivity of 85%. The increased sensitivity
of the image-assisted Abram needle biopsy technique used in
this study had been attributed to its use in a pleural thickening
of 1 cm or more, and by using a tangential approach, to
achieve adequate diagnostic samples, in patients with thin
pleural thickening less than 1 cm. Moreover, patients that
showed no pleural thickening on the CT scan, were not in-
cluded in our study.
Metintas and co-workers [18], randomly assigned 124 pa-
tients with effusions not diagnosed by cytology to undergo
628 A.Sh. Mohamed et al.either Abrams needle biopsy guided by CT ﬁndings or medical
thoracoscopy. In the CT-guided pleural biopsy group, the
diagnostic sensitivity was 87.5%, compared with 94.1% in
the thoracoscopy group (P = 0.252).
A study by Maskell et al. [19], found that CT guidance sig-
niﬁcantly increases the diagnostic yield in the setting of pleural
thickening. In their study CT-guided CNB had a sensitivity of
87%, compared with unaided Abrams needle biopsy that had a
sensitivity of only 44% (P= 0.02).
Conclusion
Blind pleural biopsy should no longer be conducted for the
study of malignant pleural disease if facilities for other tech-
niques are available. Image-assisted Abram needle and tho-
racoscopic biopsies have similarly high diagnostic rates, and
are complementary techniques used in different clinical situa-
tions. Hence, an image-assisted Abram needle is effective for
speciﬁc diagnosis in patients with undiagnosed exudative pleu-
ral effusion, with medical thoracoscopy being reserved for the
small number of cases who are not diagnosed with closed
biopsies.
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